Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by King Faisal Specialist Hospital & Research Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:
NCT01490957
First received: December 11, 2011
Last updated: NA
Last verified: December 2011
History: No changes posted
  Purpose

Functional Assessment of Cancer Therapy - Bone Marrow Transplant


Condition Intervention
Hodgkin Disease
Lymphoma, Non-Hodgkin
Other: Database

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT)

Resource links provided by NLM:


Further study details as provided by King Faisal Specialist Hospital & Research Center:

Estimated Enrollment: 113
Study Start Date: March 2008
Intervention Details:
    Other: Database
    Database
    Other Name: Database of Newly Diagnosed HD and NHL
Detailed Description:

Functional Assessment of Cancer Therapy - Bone Marrow Transplant (FACT-BMT)

  Eligibility

Ages Eligible for Study:   14 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Lymphoma database

Criteria

Inclusion Criteria:

  • Patients with newly diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma

Exclusion Criteria:

  • Patients with diagnosis other than HD and NHL.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01490957

Contacts
Contact: A Al-Zahrani, M.D. +966-1-4423949

Locations
Saudi Arabia
Kfsh & Rc Recruiting
Riyadh, Saudi Arabia
Sponsors and Collaborators
King Faisal Specialist Hospital & Research Center
Investigators
Principal Investigator: A Al-Zahrani, M.D. KFSH & RC
  More Information

No publications provided

Responsible Party: King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier: NCT01490957     History of Changes
Other Study ID Numbers: RAC# 2071-079, RAC# 2071-079
Study First Received: December 11, 2011
Last Updated: December 11, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by King Faisal Specialist Hospital & Research Center:
HD
NHL

Additional relevant MeSH terms:
Hodgkin Disease
Lymphoma, Non-Hodgkin
Lymphoma
Neoplasms by Histologic Type
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases

ClinicalTrials.gov processed this record on September 18, 2014